News

Shaw Rietkerk Joins Synapse Health as COO to Advance DME

Shaw Rietkerk Joins Synapse Health as COO to Advance DME

Shaw Rietkerk Takes on COO Role at Synapse Health

Synapse Health has recently announced an exciting addition to its leadership team with the appointment of Shaw Rietkerk as Chief Operating Officer. With a solid background in the durable medical equipment (DME) industry, Rietkerk's expertise aligns perfectly with the company's mission to shift towards value-based care.

Driving Innovation in Durable Medical Equipment

In his new position, Shaw Rietkerk will spearhead Synapse's core operations and revenue cycle management initiatives. His appointment heralds a new era for the company as it seeks to enhance service quality for patients, prescribers, and supplier associates. Under Rietkerk's leadership, Synapse is poised to implement best-in-class practices that focus on improving operational efficiency and patient outcomes.

Rietkerk's Impressive Track Record

Prior to joining Synapse, Rietkerk played a pivotal role as Chief Operating Officer at AdaptHealth. During his tenure, he was instrumental in steering the company's exponential growth trajectory through innovation in operations and revenue cycle management. Additionally, his experience as EVP and General Manager at Brightree further strengthens his capability in this new role.

Building Stronger Partnerships

Reflecting on Rietkerk’s capabilities, Cory Roberts, co-founder of Synapse Health, stated, "Shaw is a respected industry veteran who understands the challenges our supplier partners face in a rapidly evolving DME landscape." His unique expertise in both Adapt and Brightree provides him with valuable insights into the challenges that suppliers encounter as they transition to value-based care.

Rietkerk's appointment comes at a time of significant growth for Synapse Health. The company continues to invest heavily in technology and AI-driven automation, aimed at optimizing workflows for suppliers and enhancing the self-service experience for patients. His role will be critical in nurturing the relationships and collaborations that are essential for mutual success within the Synapse model.

Enhancing the Supplier Experience

Rietkerk's firsthand experience as a supplier partner during Synapse's initial risk-based model launch has equipped him with a deep understanding of the pivotal changes needed in the industry. He expressed enthusiasm about the opportunity, stating, "Joining Synapse felt like a once-in-a-lifetime opportunity to drive meaningful change in an industry where I have spent much of my career. I am excited to work with our incredible network of partners—many of whom are longtime colleagues and friends—to drive the industry forward by addressing the financial and operational complexities of change together."

About Synapse Health

Founded with the vision of accelerating the DME industry's transition to value-based care, Synapse Health empowers high-quality DME suppliers of various sizes. The company's model is centered around advocating for its partners while promoting patient-first solutions for sustained success.

Synapse believes in collaborative industry dialogue and partnerships, championing the vital role DME suppliers play in the evolving healthcare landscape. They invite stakeholders who share their commitment to engage in meaningful discussions to drive forward in this mission.

If interested in collaboration or learning more about how Synapse Health is revolutionizing the DME sector, potential partners can reach out to the company directly.

Frequently Asked Questions

What is Shaw Rietkerk's new role at Synapse Health?

Shaw Rietkerk has been appointed as the Chief Operating Officer, where he will lead core operations and revenue cycle management.

What experience does Rietkerk bring to Synapse Health?

Rietkerk comes with extensive experience from AdaptHealth and Brightree, enhancing his understanding of value-based care and operational efficiencies.

What are Synapse Health's goals under Rietkerk's leadership?

The company aims to improve service quality for patients and suppliers while adopting innovative technologies to streamline workflows.

How does Rietkerk’s experience benefit Synapse Health?

His insight from being a supplier partner during the launch of Synapse's risk-based model will help strengthen supplier relationships in their transition to value-based care.

What is the mission of Synapse Health?

Synapse Health's mission is to facilitate the DME industry's shift to value-based care, supporting suppliers through collaborative partnerships and advocacy.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Uber Data Breach: Class Action Investigation Begins

Updated Category News Views 74

When Tech Meets Trouble: Uber's Data Breach Picture this: the hum of Uber rides weaving through your city, drivers none the wiser that personal info has been pried from the vaults thanks to their tech partner, Fireworks AI. Uber, folks, is in hot water once again. This isn’t just another tech hiccup; it's a legal whirlwind brewing up courtesy of Edelson Lechtzin LLP, a...

Continue Reading
AppLovin Legal Woes: A Deep Dive into Investor Claims

Updated Category News Views 186

AppLovin Faces Legal Heat and Market Scrutiny Bitter truth has a way of crashing like a wave, and AppLovin (NASDAQ: APP) is feeling the brunt of it. Now knee-deep in a securities class action, the firm’s been accused of selling fairy tales about its AI capabilities, leaving investors clutching at substantial losses. If you’ve been banking on their promises between...

Continue Reading
Servier's Data on Tovorafenib Shows Promise in pLGG

Updated Category News Views 193

New Light on a Critical Challenge Talk about a fight in the dark. Pediatric low-grade glioma (pLGG) is a menace that families dread, an uphill battle with odds that feel relentless. Enter Servier and its four-year updated data on OJEMDA® (tovorafenib), a beacon of hope for kids battling these tricky brain tumors. Results, presented at the SNO meeting, are fresh off the...

Continue Reading
Advanta's Game-Changer: Acquiring Misr Hytech to Expand in Africa

Updated Category News Views 218

Advanta's Strategic Move into Africa Alright, let's cut to the chase. Advanta is making a big splash with its acquisition of Misr Hytech, a move that's going to shake things up in Africa's agricultural sector. This isn't just another merger to gloss over with your morning coffee. We're talking about a deal that's supposed to wrap up by January 31, 2027, bringing together...

Continue Reading
CARsgen's CAR-T Breakthrough on China's Insurance List

Updated Category News Views 166

A Game Changer for CAR-T Therapies There's a breeze of optimism blowing from Shanghai these days—a rare sensation in this market of endless skirmishes. CARsgen Therapeutics Holdings Limited, a company entrenched in the development of cutting-edge CAR T-cell therapies, just notched a victory. They've announced that their CAR T-cell therapy product, satricabtagene...

Continue Reading
Novo's CagriSema Trial Shows Promising Obesity Results

Updated Category News Views 255

Novo's Latest Weight Loss Gamble Well, look what we have here. Novo Nordisk is shaking up the obesity treatment scene with some bold numbers from their REDEFINE 9 trial. The investigational CagriSema combo of amylin analog and GLP-1 receptor agonist has churned out an eyeball-popping near 21% weight loss. For context, we're staring down the barrel of numbers far meatier...

Continue Reading
BETR's Slide: Investors Face Big Losses, Leadership Shift

Updated Category News Views 129

BETR Investors Left in the Lurch It's a real trainwreck, folks. Better Home & Finance Holding Company, trading under NASDAQ:BETR, is in the spotlight for all the wrong reasons. The company expanded the class period for its investor lawsuit to include even more dates between March and August 2026, reflecting a torturous ride for shareholders. Their stock cratered by a...

Continue Reading
HiTHIUM Joins Cambridge to Boost Global Energy Storage

Updated Category News Views 372

HiTHIUM and Cambridge's New Energy Venture There's a big splash coming out of Xiamen, folks. HiTHIUM, a heavyweight in the energy storage sector, has decided to team up with the University of Cambridge. They inked a deal aiming to bridge the academic ivory tower with industrial grit, focusing on long-duration energy storage. It was all sealed during the Global Energy...

Continue Reading
LaserAway Expands to 244 Clinics Over 20 Years

Updated Category News Views 203

A Milestone in Aesthetic Dermatology Twenty years, folks. That's a long haul for most businesses, let alone one in the fickle field of aesthetic dermatology. LaserAway, the juggernaut in this arena, has just opened its 244th clinic at 6300 Kingery Hwy in Willowbrook, IL. Nothing to be sneezed at. Imagine running a business, let alone one that's been amping up aesthetic...

Continue Reading
EZaccessMD Data Breach: Class Action Lawsuit Looms

Updated Category News Views 115

Data breaches are the bogeyman no one wants lurking in the shadows, and when it’s your personal info at stake, folks rightfully squirm. This recent fiasco at EZaccessMD is one of those unsettling incidents. The word on the street isn't pretty: sensitive medical data has slipped through the cracks, leaving Edelson Lechtzin LLP, a heavyweight in class action maneuvers, to...

Continue Reading

Top 5 Most Recently Viewed Articles

AngioDynamics' NanoKnife® System Receives FDA Clearance

Updated Category News Views 191

Introduction to AngioDynamics' Innovation AngioDynamics, Inc. (NASDAQ: ANGO), a forward-thinking medical technology firm, has made significant strides in restoring healthy blood flow and enhancing cancer treatment options. Recently, the company announced its accomplishment in receiving FDA 510(k) clearance for its advanced NanoKnife System, specifically designed for...

Continue Reading
Analyst Predicts iPhone Dominance in Apple's Future Revenues

Updated Category News Views 197

Apple's Revenue Outlook and iPhone Influence A recent analysis by Needham paints a promising picture for Apple Inc (NASDAQ: AAPL) as the company prepares for fiscal year 2025. Analyst Laura Martin affirmed a buy rating for Apple, setting an impressive price target of $260. This forecast is based on a well-crafted Discounted Cash Flow (DCF) model, which includes a cash tax...

Continue Reading
Sitetracker's Record Growth and Vision for Future Success

Updated Category News Views 398

Remarkable Achievements in 2024 for Sitetracker Sitetracker has reached significant milestones marking the close of its fiscal year with outstanding growth and exciting plans for the upcoming year. As a leader in the field of asset lifecycle management, they have positioned themselves strongly in markets worldwide, focusing on providing tools for various critical...

Continue Reading
Olympus Showcases Innovative ENT Solutions at Major Meetings

Updated Category News Views 176

Olympus Highlights Cutting-Edge ENT Solutions Olympus Corporation of the Americas, a leading medical technology company committed to enhancing health and safety, will unveil its extensive ENT portfolio at upcoming annual physician meetings. Attendees will have the opportunity to see how Olympus integrates hybrid endoscopy with advanced imaging and content management...

Continue Reading
Exciting Launch of Tech Mahindra Chess League Season 3

Updated Category News Views 101

Tech Mahindra Global Chess League Season 3 Launches with Excitement The Global Chess League (GCL) has officially begun its Season 3, and excitement fills the air as six teams are set to compete in 34 matches for the coveted championship trophy. The league kicked off at Mumbai's Royal Opera House, a perfect venue for this grand event. Spectacular Opening Ceremony in Mumbai...

Continue Reading